$22.5Bn+ Molecular Diagnostics Market Insights, 2025 - Featuring Company Analysis of Roche Diagnostics, Abbott Laboratories, Myriad Genetics, Qiagen, and bioMerieux
DUBLIN, Jan. 29, 2020 /PRNewswire/ -- The "Molecular Diagnostics Market Share & Global Forecast, By Application, Technology, End User, Regions, Companies" report has been added to ResearchAndMarkets.com's offering.
This report provides a complete analysis of Molecular Diagnostics Market.
Global Molecular Diagnostics Market is Likely to Surpass US$ 22.5 Billion by the End of Year 2025
Increasing prevalence of Infectious diseases such as Influenza, HPV, Hepatitis, HIV and Tuberculosis despite rise in sanitation practices globally. In the past, antimicrobials medicines were used to fight powerful infectious disease but slowly in today's time antimicrobial agent is not able to give the desired results because the problem of drug resistant occurs in many people across the world.
Nowadays, a new diagnostic procedure is being followed to fight infectious disease like molecular diagnostic test is very effective which is quite fast and precise. The number of cancer patients is increasing very fast, so it is believed that in the coming time the molecular diagnostic test market will be growing at rapid pace.
There are various reasons that will propel the market growth in forecast year; rising incidence rate of infectious disease, increasing incidence rate of cancer of all type, increasing people awareness regarding molecular diagnostic, rapid technological growth, widely acceptance of personalized medicine, rising healthcare infrastructure, increasing healthcare per capita expenditure across the developed and developing nation, accuracy of diagnosis, growing population of cardiovascular and neurological disorder etc. In addition, increasing prevalence of genetic disorder will further boost the market in forecast period of time.
The report provides complete insight of market by End-user segments: Hospitals & Academic Laboratories, Clinics & Commercial Laboratories and Others. According to research, Hospitals & Academic Laboratories will hold the largest market in global molecular diagnostic test market in forecast period of time.
Key Topics Covered
1. Executive Summary
2. Global Molecular Diagnostic Market
3. Market Share - Global Molecular Diagnostics
3.1 By Application
3.2 By Technology
3.3 By Countries
3.4 By Companies
4. Application - Molecular Diagnostics Market
4.1 Infectious Diseases
4.1.1 Hospital Acquired Infections (HAI)
4.1.2 HIV / HCV Testing
4.1.3 STD Testing
4.1.4 HPV Testing
4.2 Blood Screening
4.3 Oncology / Cancer
4.3.1 Breast
4.3.2 Colorectal
4.3.3 Prostate
4.3.4 Others
4.4 Genetic Testing
4.5 HLA (Tissue Typing)
4.6 Microbiology
4.7 Cardiovascular Diseases
4.8 Neurological Diseases
4.9 Pharmacogenomics
4.10 Others
5. Technology - Molecular Diagnostics Market
5.1 PCR
5.2 Transcription-Mediated Amplification (TMA)
5.3 Hybridiazation (In-situ Hybridiazation & FISH)
5.4 DNA Sequencing & NGS
5.5 Microarray
5.6 Others
6. Region - Molecular Diagnostics Market
6.1 United States
6.2 Europe
6.3 India
6.4 China
6.5 Japan
6.6 Brazil
6.7 South Korea
6.8 Mexico
6.9 Russia
6.10 Rest of World (ROW)
7. End Users - Molecular Diagnostics Market
7.1 Hospitals & Academic Laboratories
7.2 Clinics and Commercial Laboratories
7.3 Others
8. Roche Diagnostics - Company Analysis
8.1 Merger & Acquisitions
8.2 Sales Analysis
9. Abbott Laboratories - Company Analysis
9.1 Merger & Acquisitions
9.2 Sales Analysis
10. Myriad Genetics - Company Analysis
10.1 Merger & Acquisitions
10.2 Sales Analysis
11. Qiagen - Company Analysis
11.1 Merger & Acquisitions
11.2 Sales Analysis
12. BioMerieux's Inc - Company Analysis
12.1 Merger & Acquisitions
12.2 Sales Analysis
13. Market Drivers
13.1 Various Developments in the Molecular Diagnostics Landscape
13.2 Integral to Traditional Labs
13.3 Improved Assay / Test Efficiencies
13.4 Targeting Antibiotic Resistance
13.5 Next Generation Ultrasensitive Molecular Diagnostics
13.6 Increasing Investment in Genomics & Proteomics Research
13.7 Technological Advances in Molecular Diagnostics
13.8 Increasing Acceptance of the Personalized Medicine
13.9 Growing Molecular Diagnostics for Food Safety
14. Challenges
14.1 Dearth of Trained Professionals
14.2 Regulatory Issues
14.3 Various Factors Slowing Growth of Molecular Diagnostics
14.4 Reimbursement Capabilities
14.5 Quality Checkpoints, Awareness & Acceptance
For more information about this report visit https://www.researchandmarkets.com/r/d69jh4
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article